# Effect of N-acetylcysteine (NAC) on Hydrogen Sulfide (H2S) in Chronic Kidney Disease (CKD)

> **NCT01232257** · PHASE3 · COMPLETED · sponsor: **A.C. Abrahams** · enrollment: 28 (actual)

## Conditions studied

- Chronic Kidney Disease
- Chronic Kidney Failure
- End Stage Kidney Disease
- End Stage Renal Disease

## Interventions

- **DRUG:** N-acetylcysteine

## Key facts

- **NCT ID:** NCT01232257
- **Lead sponsor:** A.C. Abrahams
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-07
- **Primary completion:** 2011-12
- **Final completion:** 2011-12
- **Target enrollment:** 28 (ACTUAL)
- **Last updated:** 2012-10-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01232257

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01232257, "Effect of N-acetylcysteine (NAC) on Hydrogen Sulfide (H2S) in Chronic Kidney Disease (CKD)". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT01232257. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*